Quick Heal Technologies Limited (NSE:QUICKHEAL)
India
· Delayed Price · Currency is INR | Market Cap | 9.09B |
| Revenue (ttm) | 2.77B |
| Net Income (ttm) | 57.60M |
| Shares Out | 54.25M |
| EPS (ttm) | 1.03 |
| PE Ratio | 162.65 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 152,780 |
| Average Volume | 208,198 |
| Open | 167.20 |
| Previous Close | 167.62 |
| Day's Range | 164.10 - 172.92 |
| 52-Week Range | 125.00 - 416.70 |
| Beta | -0.21 |
| RSI | 53.43 |
| Earnings Date | May 30, 2026 |
About Quick Heal Technologies
Quick Heal Technologies Limited engages in the provision of security software products and solutions to consumers, small businesses, government establishments, and corporate houses in India and internationally. It offers antivirus solutions, including total security, internet security, antivirus pro, security for mac, total security for android, mobile security, total security multi-device, and internet security essentials under the Quick Heal brand, as well as consumer fraud prevention products comprising the Quick Heal AntiFraud.AI. The compa... [Read more]
Financial Performance
In fiscal year 2025, Quick Heal Technologies's revenue was 2.80 billion, a decrease of -4.19% compared to the previous year's 2.92 billion. Earnings were 50.40 million, a decrease of -79.21%.
Financial StatementsNews
Quick Heal shares jump over 3% after winning RS 64.25 crore cybersecurity contract from NFSU-RIC
Quick Heal Technologies saw its shares move over 3% in early trade after the company announced a significant contract win...
Quick Heal Technologies secures Rs 64.25 crore contract from NFSU-RIC for Integrated Cyber Security Solutions
Quick Heal Technologies Limited has signed a major contract with the NFSU Research and Innovation Council (NFSU-RIC) to implement a...
Quick Heal version26 Redefines Digital Privacy with Predictive AI and Real-Time Fraud Prevention
Business Wire India Industry-first security suite combining AI and Privacy to deliver predictive threat detection and complete fraud protection Enhanced...
Q1 2026 Quick Heal Technologies Ltd Earnings Call Transcript
Q1 2026 Quick Heal Technologies Ltd Earnings Call Transcript
Quick Heal Technologies Ltd (BOM:539678) Q2 2026 Earnings Call Highlights: Strong International ...
Quick Heal Technologies Ltd (BOM:539678) Q2 2026 Earnings Call Highlights: Strong International Growth Amidst Consumer Challenges
Q2 2026 Quick Heal Technologies Ltd Earnings Call Transcript
Q2 2026 Quick Heal Technologies Ltd Earnings Call Transcript
Quick Heal Technologies Transcript: Q2 25/26
Q2 FY26 delivered strong revenue and margin growth, led by seasonal consumer strength and robust enterprise momentum. Enterprise is set to overtake consumer as the main revenue driver, with new products and government demand fueling future growth.
Quick Heal Technologies shares jump over 6% after Q2 net profit surges 91% YoY
Shares of Quick Heal Technologies Ltd. rallied more than 6% in early trade on Thursday after the cybersecurity company reported...
Quick Heal Technologies Transcript: Q1 25/26
Q1 FY 2026 saw revenue decline to ₹57 crore due to consumer softness and deferred enterprise deals, with EBITDA at -₹9.7 crore. Strategic investments in innovation, international growth, and a healthy order book position the company for future recovery.
Quick Heal Technologies shares drop nearly 2% after CEO Vishal Salvi resigns
Shares of Quick Heal Technologies Limited fell close to 2% on Wednesday after the company announced the resignation of its Chief Executive Officer and Key Managerial Personnel, Vishal Salvi. The stock...
Quick Heal Technologies Transcript: Q4 24/25
FY25 saw revenue decline to INR 280 crore and negative EBITDA, driven by consumer headwinds and delayed government deals, but enterprise and cloud segments grew to 40% and 31% of revenue, respectively. Multiple new products launched, with a strong pipeline and order book supporting a positive FY26 outlook.
IDRBT unveils revamped platform for enhanced cybersecurity in banking sector
Hyderabad: The Institute for Development and Research in Banking Technology (IDRBT), in collaboration with Quick Heal Technologies Limited, announced .
2025 Quick Heal Technologies Ltd Earnings Call Transcript
2025 Quick Heal Technologies Ltd Earnings Call Transcript
Quick Heal Technologies Transcript: Q3 24/25
Q3 FY25 saw a 14% YoY revenue decline due to consumer and government headwinds, but a strong order pipeline, new product launches, and regulatory-driven demand position the company for growth in FY26. Deferred revenue and order book reached new highs, with cash reserves stable at INR 190 crore.
Quick Heal Technologies Transcript: Q2 24/25
Revenue grew 5% sequentially but fell 6% year-over-year, with EBITDA turning positive in H1 FY25. AntiFraud.AI was launched as a new B2C product, while core products remain the main revenue driver. Margins are under pressure due to ongoing R&D and new product investments.
BSE Smallcap Index down as these stocks fell up to 15.25%
The BSE Smallcap index witnessed a decline today, with stocks like Manappuram Finance dropping by 15.25%, followed by Mahanagar Gas, which fell by 13.27%. Quick Heal Technologies also saw a sharp dip ...
Quick Heal stock drops 8.72% following Q2 results announcement
Quick Heal Technologies (NSE: QUICKHEAL) saw its stock decline by 8.72% to ₹694.95 as of 9:24 AM, following the announcement of its Q2 FY25 results. The stock opened at ₹732.40, reached a high of ₹734...
This antivirus Android app is 'fake' and why you need to delete it
Cybersecurity firm Quick Heal Technologies uncovers a fake antivirus app, 'AntiVirus - Virus Cleaner,' on Google Play Store. Despite mimicking legitimate antivirus functionalities, the app only displa...
IRCTC & 5 other big online scams that people are losing money to
Quick Heal Technologies has alerted consumers about rising cyber threats with the upcoming festival season. These include fake shopping websites mimicking legitimate ones, malicious banking reward app...
Quick Heal Technologies Transcript: Q1 24/25
Q1 FY25 delivered 37% year-on-year revenue growth, driven by strong consumer and enterprise performance, new product launches, and improved profitability. R&D and innovation remain key priorities, with the DPDP Act expected to boost future demand.